{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T19:35:50Z","timestamp":1775849750688,"version":"3.50.1"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,7,1]]},"DOI":"10.1093\/aje\/kwj152","type":"journal-article","created":{"date-parts":[[2006,5,4]],"date-time":"2006-05-04T20:51:13Z","timestamp":1146775873000},"page":"56-62","source":"Crossref","is-referenced-by-count":43,"title":["Risk Factors for the Incidence of Endometrial Cancer according to the Aggressiveness of Disease"],"prefix":"10.1093","volume":"164","author":[{"given":"Jocelyn M.","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babette S.","family":"Saltzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer A.","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda F.","family":"Voigt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shirley A. A.","family":"Beresford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deirdre A.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel S.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,5,4]]},"reference":[{"key":"key\n\t\t\t\t20171010151651_BIB1","doi-asserted-by":"crossref","unstructured":"McDonald TW, Annegers JF, O'Fallon WM, et al. Exogenous estrogen and endometrial carcinoma: case-control and incidence study. Am J Obstet Gynecol1977;127:572\u201380.","DOI":"10.1016\/0002-9378(77)90351-9"},{"key":"key\n\t\t\t\t20171010151651_BIB2","doi-asserted-by":"crossref","unstructured":"Collins J, Donner A, Allen LH, et al. Oestrogen use and survival in endometrial cancer. Lancet1980;2:961\u20134.","DOI":"10.1016\/S0140-6736(80)92115-7"},{"key":"key\n\t\t\t\t20171010151651_BIB3","doi-asserted-by":"crossref","unstructured":"Abeler VM, Kjorstad KE. Serous papillary carcinoma of the endometrium: a histopathological study of 22 cases. Gynecol Oncol1990;39:266\u201371.","DOI":"10.1016\/0090-8258(90)90250-O"},{"key":"key\n\t\t\t\t20171010151651_BIB4","doi-asserted-by":"crossref","unstructured":"Wilson TO, Podratz KC, Gaffey TA, et al. Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma. Am J Obstet Gynecol1990;162:418\u201323; discussion 423\u20136.","DOI":"10.1016\/0002-9378(90)90399-R"},{"key":"key\n\t\t\t\t20171010151651_BIB5","doi-asserted-by":"crossref","unstructured":"Mariani A, Sebo TJ, Katzmann JA, et al. Pretreatment assessment of prognostic indicators in endometrial cancer. Am J Obstet Gynecol2000;182:1535\u201344.","DOI":"10.1067\/mob.2000.107328"},{"key":"key\n\t\t\t\t20171010151651_BIB6","doi-asserted-by":"crossref","unstructured":"Alektiar KM, McKee A, Lin O, et al. The significance of the amount of myometrial invasion in patients with stage IB endometrial carcinoma. Cancer2002;95:316\u201321.","DOI":"10.1002\/cncr.10660"},{"key":"key\n\t\t\t\t20171010151651_BIB7","doi-asserted-by":"crossref","unstructured":"Mack TM, Pike MC, Henderson BE, et al. Estrogens and endometrial cancer in a retirement community. N Engl J Med1976;294:1262\u20137.","DOI":"10.1056\/NEJM197606032942304"},{"key":"key\n\t\t\t\t20171010151651_BIB8","doi-asserted-by":"crossref","unstructured":"Gray LA Sr, Christopherson WM, Hoover RN. Estrogens and endometrial carcinoma. Obstet Gynecol1977;49:385\u20139.","DOI":"10.1097\/00006254-197709000-00023"},{"key":"key\n\t\t\t\t20171010151651_BIB9","doi-asserted-by":"crossref","unstructured":"Antunes CM, Strolley PD, Rosenshein NB, et al. Endometrial cancer and estrogen use. Report of a large case-control study. N Engl J Med1979;300:9\u201313.","DOI":"10.1056\/NEJM197901043000103"},{"key":"key\n\t\t\t\t20171010151651_BIB10","doi-asserted-by":"crossref","unstructured":"Hulka BS, Kaufman DG, Fowler WC Jr, et al. Predominance of early endometrial cancers after long-term estrogen use. JAMA1980;244:2419\u201322.","DOI":"10.1001\/jama.244.21.2419"},{"key":"key\n\t\t\t\t20171010151651_BIB11","doi-asserted-by":"crossref","unstructured":"Smith DC, Prentice RL, Bauermeister DE. Endometrial carcinoma: histopathology, survival, and exogenous estrogens. Gynecol Obstet Invest1981;12:169\u201379.","DOI":"10.1159\/000299600"},{"key":"key\n\t\t\t\t20171010151651_BIB12","doi-asserted-by":"crossref","unstructured":"La Vecchia C, Franceschi S, Gallus G, et al. Prognostic features of endometrial cancer in estrogen users and obese women. Am J Obstet Gynecol1982;144:387\u201390.","DOI":"10.1016\/0002-9378(82)90241-1"},{"key":"key\n\t\t\t\t20171010151651_BIB13","doi-asserted-by":"crossref","unstructured":"Nyholm HC, Nielsen AL, Norup P. Endometrial cancer in postmenopausal women with and without previous estrogen replacement treatment: comparison of clinical and histopathological characteristics. Gynecol Oncol1993;49:229\u201335.","DOI":"10.1006\/gyno.1993.1112"},{"key":"key\n\t\t\t\t20171010151651_BIB14","unstructured":"Brinton LA, Hoover RN. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group. Obstet Gynecol1993;81:265\u201371."},{"key":"key\n\t\t\t\t20171010151651_BIB15","doi-asserted-by":"crossref","unstructured":"Prat J. Prognostic parameters of endometrial carcinoma. Hum Pathol2004;35:649\u201362.","DOI":"10.1016\/j.humpath.2004.02.007"},{"key":"key\n\t\t\t\t20171010151651_BIB16","unstructured":"Sherman ME, Sturgeon S, Brinton LA, et al. Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas. Mod Pathol1997;10:963\u20138."},{"key":"key\n\t\t\t\t20171010151651_BIB17","unstructured":"Sturgeon SR, Sherman ME, Kurman RJ, et al. Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors. Cancer Epidemiol Biomarkers Prev1998;7:231\u20135."},{"key":"key\n\t\t\t\t20171010151651_BIB18","doi-asserted-by":"crossref","unstructured":"Doherty JA, Weiss NS, Freeman RJ, et al. Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev2005;14:357\u201366.","DOI":"10.1158\/1055-9965.EPI-04-0479"},{"key":"key\n\t\t\t\t20171010151651_BIB19","doi-asserted-by":"crossref","unstructured":"Reed SD, Voigt LF, Beresford SA, et al. Dose of progestin in postmenopausal-combined hormone therapy and risk of endometrial cancer. Am J Obstet Gynecol2004;191:1146\u201351.","DOI":"10.1016\/j.ajog.2004.04.041"},{"key":"key\n\t\t\t\t20171010151651_BIB20","doi-asserted-by":"crossref","unstructured":"Hill DA, Weiss NS, Beresford SA, et al. Continuous combined hormone replacement therapy and risk of endometrial cancer. Am J Obstet Gynecol2000;183:1456\u201361.","DOI":"10.1067\/mob.2000.108081"},{"key":"key\n\t\t\t\t20171010151651_BIB21","doi-asserted-by":"crossref","unstructured":"Beresford SA, Weiss NS, Voigt LF, et al. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women. Lancet1997;349:458\u201361.","DOI":"10.1016\/S0140-6736(96)07365-5"},{"key":"key\n\t\t\t\t20171010151651_BIB22","doi-asserted-by":"crossref","unstructured":"Shapiro JA, Weiss NS, Beresford SA, et al. Menopausal hormone use and endometrial cancer, by tumor grade and invasion. Epidemiology1998;9:99\u2013101.","DOI":"10.1097\/00001648-199801000-00020"},{"key":"key\n\t\t\t\t20171010151651_BIB23","unstructured":"Hankey BF, Ries LA, Edwards BK. The Surveillance, Epidemiology, and End Results Program: a national resource. Cancer Epidemiol Biomarkers Prev1999;8:1117\u201321."},{"key":"key\n\t\t\t\t20171010151651_BIB24","doi-asserted-by":"crossref","unstructured":"Waksberg J. Sampling methods for random digit dialing. J Am Stat Soc1978;73:40\u20136.","DOI":"10.1080\/01621459.1978.10479995"},{"key":"key\n\t\t\t\t20171010151651_BIB25","doi-asserted-by":"crossref","unstructured":"Marchbanks PA, McDonald JA, Wilson HG, et al. The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. Ann Epidemiol2002;12:213\u201321.","DOI":"10.1016\/S1047-2797(01)00274-5"},{"key":"key\n\t\t\t\t20171010151651_BIB26","doi-asserted-by":"crossref","unstructured":"Beresford SA, Coker AL. Pictorially assisted recall of past hormone use in case-control studies. Am J Epidemiol1989;130:202\u20135.","DOI":"10.1093\/oxfordjournals.aje.a115313"},{"key":"key\n\t\t\t\t20171010151651_BIB27","doi-asserted-by":"crossref","unstructured":"Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol1982;116:114\u201322.","DOI":"10.1093\/oxfordjournals.aje.a113386"},{"key":"key\n\t\t\t\t20171010151651_BIB28","doi-asserted-by":"crossref","unstructured":"Strom BL, Schinnar R. An interview strategy was critical for obtaining valid information on the use of hormone replacement therapy. J Clin Epidemiol2004;57:1210\u201313.","DOI":"10.1016\/j.jclinepi.2004.04.001"},{"key":"key\n\t\t\t\t20171010151651_BIB29","doi-asserted-by":"crossref","unstructured":"Jain MG, Rohan TE, Howe GR. Agreement of self-reported use of menopausal hormone replacement therapy with physician reports. Epidemiology1999;10:260\u20133.","DOI":"10.1097\/00001648-199905000-00012"},{"key":"key\n\t\t\t\t20171010151651_BIB30","unstructured":"Lurain JR. Uterine cancer. In: Berek JS, Adashi EY, Hillard PA, eds. Novak's gynecology. Baltimore, MD: Williams & Wilkins, 1996:1057\u2013110."},{"key":"key\n\t\t\t\t20171010151651_BIB31","unstructured":"Cook LS, Doherty JA, Weiss NS, et al. Endometrial cancer: epidemiology and molecular endocrinology. In: Henderson BE, Ponder B, Ross RK, eds. Hormones, genes, and cancer. New York, NY: Oxford University Press, Inc, 2003:371\u201397."},{"key":"key\n\t\t\t\t20171010151651_BIB32","unstructured":"Cook LS, Weiss NS. Endometrial cancer. In: Goldman MB, Hatch MC, eds. Women and health. London, United Kingdom: Academic Press, 1999:916\u201331."},{"key":"key\n\t\t\t\t20171010151651_BIB33","doi-asserted-by":"crossref","unstructured":"Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA2002;288:321\u201333.","DOI":"10.1001\/jama.288.3.321"},{"key":"key\n\t\t\t\t20171010151651_BIB34","doi-asserted-by":"crossref","unstructured":"Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial. JAMA2003;289:3243\u201353.","DOI":"10.1001\/jama.289.24.3243"},{"key":"key\n\t\t\t\t20171010151651_BIB35","doi-asserted-by":"crossref","unstructured":"Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet2003;362:419\u201327.","DOI":"10.1016\/S0140-6736(03)14596-5"},{"key":"key\n\t\t\t\t20171010151651_BIB36","doi-asserted-by":"crossref","unstructured":"Weiderpass E, Adami HO, Baron JA, et al. Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst1999;91:1131\u20137.","DOI":"10.1093\/jnci\/91.13.1131"},{"key":"key\n\t\t\t\t20171010151651_BIB37","doi-asserted-by":"crossref","unstructured":"Weiss NS, Szekely DR, English DR, et al. Endometrial cancer in relation to patterns of menopausal estrogen use. JAMA1979;242:261\u20134.","DOI":"10.1001\/jama.242.3.261"},{"key":"key\n\t\t\t\t20171010151651_BIB38","doi-asserted-by":"crossref","unstructured":"Smith DC, Prentice R, Thompson DJ, et al. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med1975;293:1164\u20137.","DOI":"10.1056\/NEJM197512042932302"},{"key":"key\n\t\t\t\t20171010151651_BIB39","doi-asserted-by":"crossref","unstructured":"Underwood PB Jr, Miller MC, Kreutner A Jr, et al. Endometrial carcinoma: the effect of estrogens. Gynecol Oncol1979;8:60\u201373.","DOI":"10.1016\/0090-8258(79)90008-8"},{"key":"key\n\t\t\t\t20171010151651_BIB40","doi-asserted-by":"crossref","unstructured":"Abeler VM, Vergote IB, Kjorstad KE, et al. Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern. Cancer1996;78:1740\u20137.","DOI":"10.1002\/(SICI)1097-0142(19961015)78:8<1740::AID-CNCR14>3.0.CO;2-Y"},{"key":"key\n\t\t\t\t20171010151651_BIB41","doi-asserted-by":"crossref","unstructured":"Carcangiu ML, Chambers JT. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma. Gynecol Oncol1992;47:298\u2013305.","DOI":"10.1016\/0090-8258(92)90130-B"},{"key":"key\n\t\t\t\t20171010151651_BIB42","doi-asserted-by":"crossref","unstructured":"Chen JL, Trost DC, Wilkinson EJ. Endometrial papillary adenocarcinomas: two clinicopathological types. Int J Gynecol Pathol1985;4:279\u201388.","DOI":"10.1097\/00004347-198512000-00001"},{"key":"key\n\t\t\t\t20171010151651_BIB43","doi-asserted-by":"crossref","unstructured":"Hendrickson M, Ross J, Eifel P, et al. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol1982;6:93\u2013108.","DOI":"10.1097\/00000478-198203000-00002"},{"key":"key\n\t\t\t\t20171010151651_BIB44","doi-asserted-by":"crossref","unstructured":"Aquino-Parsons C, Lim P, Wong F, et al. Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO stage 1a and 1b endometrial adenocarcinoma: treatment implications. Gynecol Oncol1998;71:83\u20136.","DOI":"10.1006\/gyno.1998.5147"},{"key":"key\n\t\t\t\t20171010151651_BIB45","doi-asserted-by":"crossref","unstructured":"Hendrickson M, Ross J, Eifel PJ, et al. Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables. Gynecol Oncol1982;13:373\u201392.","DOI":"10.1016\/0090-8258(82)90076-2"},{"key":"key\n\t\t\t\t20171010151651_BIB46","unstructured":"Lauchlan SC. Tubal (serous) carcinoma of the endometrium. Arch Pathol Lab Med1981;105:615\u201318."},{"key":"key\n\t\t\t\t20171010151651_BIB47","unstructured":"Walker AN, Mills SE. Serous papillary carcinoma of the endometrium. A clinicopathologic study of 11 cases. Diagn Gynecol Obstet1982;4:261\u20137."},{"key":"key\n\t\t\t\t20171010151651_BIB48","doi-asserted-by":"crossref","unstructured":"Sutton GP, Brill L, Michael H, et al. Malignant papillary lesions of the endometrium. Gynecol Oncol1987;27:294\u2013304.","DOI":"10.1016\/0090-8258(87)90249-6"},{"key":"key\n\t\t\t\t20171010151651_BIB49","doi-asserted-by":"crossref","unstructured":"Creasman WT, Kohler MF, Odicino F, et al. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium. Gynecol Oncol2004;95:593\u20136.","DOI":"10.1016\/j.ygyno.2004.08.019"}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/aje\/article-pdf\/164\/1\/56\/183437\/kwj152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T12:04:09Z","timestamp":1555589049000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/aje\/article\/164\/1\/56\/80957\/Risk-Factors-for-the-Incidence-of-Endometrial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,4]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2006,5,4]]},"published-print":{"date-parts":[[2006,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwj152","relation":{},"ISSN":["1476-6256","0002-9262"],"issn-type":[{"value":"1476-6256","type":"electronic"},{"value":"0002-9262","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,7,1]]},"published":{"date-parts":[[2006,5,4]]}}}